Menactra®
Menactra® is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.
It is approved for use in individuals 9 months through 55 years of age.
Disclaimer: Patient images depicted here are fictitious and meant for illustrative purpose only. Any resemblance to any person, living or dead is purely coincidental.
